Mirna Hits a New Low After Halting Clinical Trial
Mirna Therapeutics shares got crushed on Wednesday, sinking to an all-time low, after the company halted a Phase 1 trial.
All Work
Chris Lange
How Analysts Are Chasing Adobe Targets Much Higher
After Adobe Systems reported fiscal third-quarter 2016 results on Tuesday, shares hit all-time highs and investors were especially pleased.
What to Expect From Bed Bath & Beyond Earnings
Bed Bath & Beyond is scheduled to report its fiscal second-quarter financial results after the markets close on Wednesday.
CarMax Earnings Fall Short of Expectations
CarMax reported mixed fiscal second-quarter results before the markets opened on Wednesday, and shares drooped.
Eleven Bio Finds Even More Pipeline Growth in M&A
Eleven Biotherapeutics announced that it has entered into a definitive agreement to acquire Viventia and its lead product candidates Vicinium and Proxinium.
FedEx Posts Solid Earnings Beat to Kick Off Fiscal 2017
FedEx Corp. (NYSE: FDX) reported fiscal first-quarter financial results after the markets closed on Tuesday. The company said that it had $2.90 in earnings per share (EPS) on $14.7 billion in revenue. The consensus…
What to Look for in Adobe Earnings
Adobe Systems is set to release its fiscal third-quarter financial results after the markets close on Tuesday.
What to Expect From FedEx Earnings
FedEx is scheduled to report its fiscal first-quarter financial results after the markets close on Tuesday.
Tobira Therapeutics Skyrockets on Allergan Acquisition
Tobira Therapeutics shares skyrocketed on Tuesday after Allergan announced that it will acquire the company.
Puma Biotech Rises on Key FDA Approval
Shares of Puma Biotechnology had a strong gain in Tuesday’s session following some positive news from the FDA on the company's breast cancer treatment.
Tessera Moves to Acquire DTS
DTS shares saw a handy gain early on Tuesday after it was announced that this company would be acquired by Tessera Technologies).
Activision and Sony Gear Up for Highly Anticipated Destiny Release
Activision Blizzard is set to deliver a highly anticipated expansion in its Destiny franchise, easily one of the most anticipated video game releases in recent history.
Ascena Retail Group Stumbles Over Q4 Earnings and Guidance
This has been a tough fiscal year for Ascena Retail, with significant store traffic headwinds and a competitive selling environment. The stock is down nearly 40% over the past weeks.
Sarepta Scores Big on Highly Contested FDA Approval
Sarepta Therapeutics cleared another hurdle related to its Duchenne muscular dystrophy treatment, and the stock practically doubled on Monday.
Vista Equity Partners Moves to Acquire Infoblox
Infoblox shares made a handy gain on Monday after the company said that it has entered into a definitive agreement to be acquired by Vista Equity Partners.
Community Health May Be Planning Sale
Shares of Community Health Systems retreated on Monday, after making a sizable gain in Friday’s session on news that the company might be pursuing an option to sell.
What Analysts Are Saying About Oracle After Earnings
Despite growing from last year, Oracle took a step back when it failed to reach analysts’ expectations in its fiscal first-quarter financial results on Thursday.
Top 7 Earnings for the Coming Week
24/7 Wall St. has put together a preview of Rite Aid, FedEx and some of the major companies reporting earnings in the coming week.
4 Companies That Destroyed Shareholders Last Week
24/7 Wall Street has picked out a few companies posting the largest losses for the week, including Novavax and VimpelCom.
10 Analyst Stock Picks Under $10 for Massive Upside
One category of analyst calls that often comes with great upside is in the small-cap and low-priced stocks. Some of these stocks trade under $10 per share.